Similarly, UBE2N has been previously reported to be overexpressed in patients with triple-negative breast cancer as well as in six different neuroblastoma cell lines (Muñiz Lino et al., 2014; Cheng et al., 2014). This evidence concerns the gene UBE2N and triple-negative breast carcinoma.